MedPath

HYOSCINE BUTYLBROMIDE INJECTION BP

HYOSCINE BUTYLBROMIDE INJECTION BP

Approved
DIN Number

02508419

Drug Class

Human

Market Date

Jun 4, 2024

Company
HC

omega laboratories limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02508419
AIG Number0104703002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A03BB01 BUTYLSCOPOLAMINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous ,  Intravenous ,  Intramuscular
AHFS Classification12:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

HYOSCINE BUTYLBROMIDEActive
Strength: 20 MG / ML
Monograph: HYOSCINE BUTYLBROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.